Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas.
Basile M, Valentini I, Attanasio R, Cozzi R, Persichetti A, Samperi I, Scoppola A, Auriemma RS, De Menis E, Esposito F, Ferrante E, Iatì G, Mazzatenta D, Poggi M, Rudà R, Tortora F, Cruciani F, Mitrova Z, Saulle R, Vecchi S, Cappabianca P, Paoletta A, Bozzao A, Caputo M, Doglietto F, Ferraù F, Lania AG, Laureti S, Lello S, Locatelli D, Maffei P, Minniti G, Peri A, Ruini C, Settanni F, Silvani A, Veronese N, Grimaldi F, Papini E, Cicchetti A. Basile M, et al. Among authors: persichetti a. Glob Reg Health Technol Assess. 2024 Jan 9;11:1-16. doi: 10.33393/grhta.2024.2601. eCollection 2024 Jan-Dec. Glob Reg Health Technol Assess. 2024. PMID: 38230389 Free PMC article.
Italian Guidelines for the Management of Prolactinomas.
Cozzi R, Simona Auriemma R, De Menis E, Esposito F, Ferrante E, Iatì G, Mazzatenta D, Poggi M, Rudà R, Tortora F, Cruciani F, Mitrova Z, Saulle R, Vecchi S, Basile M, Cappabianca P, Paoletta A, Papini E, Persichetti A, Samperi I, Scoppola A, Bozzao A, Caputo M, Doglietto F, Ferraù F, Lania AG, Laureti S, Lello S, Locatelli D, Maffei P, Minniti G, Peri A, Ruini C, Settanni F, Silvani A, Veronese N, Grimaldi F, Attanasio R. Cozzi R, et al. Among authors: persichetti a. Endocr Metab Immune Disord Drug Targets. 2023;23(12):1459-1479. doi: 10.2174/1871530323666230511104045. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 37171003 Free PMC article.
Italian Guidelines for the Management of Non-Functioning Benign and Locally Symptomatic Thyroid Nodules.
Papini E, Crescenzi A, D'Amore A, Deandrea M, De Benedictis A, Frasoldati A, Garberoglio R, Guglielmi R, Pio Lombardi C, Mauri G, Elisa Miceli R, Puglisi S, Rago T, Salvatore D, Triggiani V, Van Doorne D, Mitrova Z, Saulle R, Vecchi S, Basile M, Scoppola A, Paoletta A, Persichetti A, Samperi I, Cozzi R, Grimaldi F, Boniardi M, Camaioni A, Elisei R, Guastamacchia E, Nati G, Novo T, Salvatori M, Spiezia S, Vallone G, Zini M, Attanasio R. Papini E, et al. Among authors: persichetti a. Endocr Metab Immune Disord Drug Targets. 2023;23(6):876-885. doi: 10.2174/1871530323666230201104112. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 36722479 Free PMC article.
Obesity management: Attitudes and practice of Italian endocrinologists.
Chianelli M, Busetto L, Attanasio R, Disoteo OE, Borretta G, Persichetti A, Samperi I, Scoppola A, Paoletta A, Grimaldi F, Papini E, Nicolucci A. Chianelli M, et al. Among authors: persichetti a. Front Endocrinol (Lausanne). 2023 Jan 17;13:1061511. doi: 10.3389/fendo.2022.1061511. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36733804 Free PMC article.
Combined Treatment with Laser Ablation and Tyrosine-Kinase Inhibitor as A Novel Multimodality Approach to Locally Advanced Thyroid Cancer: A Case Report.
Persichetti A, Monti S, Coccaro C, Presciuttini F, Deiana MG, Bizzarri G, Bianchini A, Triggiani V, Papini E, Guglielmi R. Persichetti A, et al. Endocr Metab Immune Disord Drug Targets. 2022;22(3):357-362. doi: 10.2174/1871530321666210830093522. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 34459381
52 results